Victoza Liraglutid Pen

Composition of Victoza Liraglutid Pen

Victoza Liraglutid Pen contains Liraglutide 6 mg/mL solution for injection (prefilled pen 3 mL; total 18 mg). It belongs to the GLP-1 receptor agonist (incretin mimetic) class of medicines.

Uses of Victoza Liraglutid Pen

Type 2 diabetes mellitus (as an adjunct to diet and exercise to improve glycaemic control); chronic weight management in adults with obesity/overweight with weight-related comorbidities (only if prescribed for this indication)

Key benefits

• Lowers fasting and post-meal blood glucose
• Helps reduce HbA1c
• Supports weight loss via appetite reduction
• Lowers risk of hypoglycaemia when not combined with insulin/sulfonylurea
• Convenient once-daily injection

How Victoza Liraglutid Pen works

Liraglutide is a GLP-1 receptor agonist that increases glucose-dependent insulin secretion and reduces inappropriate glucagon release. It also slows gastric emptying and reduces appetite, helping lower blood glucose and support weight loss.

How to take Victoza Liraglutid Pen

Subcutaneous injection once daily at the same time each day, independent of meals. Inject into abdomen, thigh, or upper arm; rotate sites and do not inject intravenously or intramuscularly. Typical titration: start 0.6 mg daily for 1 week, then 1.2 mg daily; may increase to 1.8 mg daily if needed (as directed by doctor). Use a new needle each time and follow pen instructions.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Victoza Liraglutid Pen as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Victoza Liraglutid Pen than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Victoza Liraglutid Pen

Most side effects of Victoza Liraglutid Pen are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• vomiting
• diarrhoea
• constipation
• abdominal pain
• decreased appetite
• dyspepsia/indigestion
• headache
• dizziness
• injection-site reactions
• hypoglycaemia (more likely with sulfonylurea/insulin)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Victoza Liraglutid Pen

Warnings and precautions

Not for type 1 diabetes or diabetic ketoacidosis. Risk of pancreatitis—seek urgent care for severe persistent abdominal pain (with/without vomiting). Contraindicated/avoid in patients with personal/family history of medullary thyroid carcinoma or MEN2; report neck lump/hoarseness/dysphagia. Use caution in severe GI disease (e.g., gastroparesis) and in renal impairment due to dehydration from GI side effects; monitor kidney function if significant vomiting/diarrhoea occurs. Monitor for gallbladder disease symptoms. Hypoglycaemia risk increases when used with insulin or sulfonylureas—dose adjustment may be needed. Do not share pens; use only with compatible needles.

Interactions with other medicines

Insulin and sulfonylureas (increased hypoglycaemia risk), other GLP-1 receptor agonists (not recommended together), drugs with narrow therapeutic index requiring rapid GI absorption may be affected due to delayed gastric emptying (monitor), warfarin/anticoagulants (monitor INR on initiation/titration), alcohol (may increase hypoglycaemia risk)

How to store Victoza Liraglutid Pen

Store unopened pens refrigerated at 2–8°C; do not freeze and keep away from freezer compartment. After first use, store refrigerated (2–8°C) or at room temperature (up to 30°C) as per label; protect from light, keep cap on, and discard after the in-use period stated on pack (commonly 30 days). Do not use if solution is cloudy/colored or contains particles.

Manufacturer and class

Manufacturer:

ABBOTT INDIA LTD

Therapeutic class:

Antidiabetic

Drug class:

GLP-1 receptor agonist (incretin mimetic)